ARSYNL Rxs GLP-1 care model is built around privacy, discretion, and licensed medical review
We believe that learning about your body, asking questions, and being your own health advocate are key to achieving optimal wellness
Explore Alternative Delivery Methods Compounded medication can sometimes offer alternative methods of delivery, perfect for patients who cannot tolerate injectables
These studies provide valuable information on the options available after achieving weight loss goals
This was a cultured human cell-line model, not an animal or human study, and cannot establish a clinical benefit, dose, or delivery method.What is the Texas Compassionate Use Program?It is Texas's medical cannabis program, established in 2015, providing regulated access to low-THC cannabis products for qualifying medical conditions.Are dialysis patients currently included in the Texas program?The policy analysis argues they should be explicitly included as a qualifying group, but describes this as a recommendation, not a change that has already occurred.What symptom burden do dialysis patients face, according to the paper?The analysis cites high rates of chronic pain, nausea, insomnia, depression, and opioid exposure among dialysis patients.Is the Texas paper based on new patient outcomes data?No

GLP-1 RAs and dual or triple agonists incorporating GIP and/or glucagon receptor activity exhibit broad metabolic benefits, including improvements in steatosis, insulin sensitivity, inflammation, and body weight